Skip to main content
Recall Canary
Baxter Healthcare: multiple drugs
← Back to all recalls
DRUG RECALLMODERATE

Baxter Healthcare: multiple drugs

Baxter recalls 17 sterile injectable drugs, including Vancomycin and Clindamycin, over CGMP deviations.

What to do

Check your inventory for the recalled products listed in the recall notice. Contact Baxter Healthcare or your healthcare provider for guidance on returning or disposing of affected products.

Recalled
Listed
Updated
Agency
FDA
Firm
Baxter Healthcare Corporation
Recall ID
99500
Status
ONGOING

Why it was recalled

Baxter Healthcare is recalling 17 injectable drug products, including Vancomycin Injection, Clindamycin Injection, Daptomycin, and others, due to CGMP deviations. The affected products include antibiotics, cardiovascular drugs, and other sterile injectables sold in GALAXY single-dose containers.

Is mine affected?

This recall covers 17 products. Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

ProductLot codeStrengthNDC / UPC
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx…NC185448, 2027, NC192910, 2028, NC195218–NDC 0338-9647-12
Clindamycin Injection USP in 5% DextroseNC185424, 2027, NC185479, NC193948900 mgNDC 0338-3814-50
Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx…NC193672, NC193795, 2028, NC194198–NDC 0338-9640-12
Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (NC188678, 2026, NC188814, NC188944, NC193610, 2027, NC1936655 mgNDC 0338-3552-48
Clindamycin Phosphate in 0.9% Sodium Chloride InjectionNC193689, 2027600 mgNDC 0338-9549-50
Daptomycin, in 0.9% Sodium Chloride InjectionNC188692, 2027500 mgNDC 0338-0714-24
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride InjectionNC177818, 2026, NC188869, 202740 mgNDC 43066-016-10
Famotidine Injection in Sodium Chloride InjectionNC188586, 2027, NC18891320 mgNDC 0338-5197-41
Show all 17 products
ProductLot codeStrengthNDC / UPC
Clindamycin Injection USP in 5% DextroseNC194075, 2027900 mgNDC 0338-4114-50
Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (NC193894, 20275 mgNDC 0338-3583-01
Nexterone (amiodarone HCI)NC177832, 2026, NC185417, NC185455, 2027, NC188593, NC188647, NC188685, NC188807, NC188838, NC188920, NC193603, NC193726, NC193788, NC193863, NC193900, 2028, NC194082, NC194112, NC194143, NC195157360 mgNDC 43066-360-20
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride InjectionNC188654, 2027, NC188821, NC193658, NC193702, 2028400 mcgNDC 0338-9557-12
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare…NC188630, NC188708, NC188791, NC188845, NC188876, NC188968, 2027, NC193719, NC193849, 2028, NC194051, NC194105, NC195171–NDC 0338-0126-12
Daptomycin, in 0.9% Sodium Chloride Injection, 1NC193856, 2028000 mgNDC 0338-0718-12
Clindamycin Injection USP in 5% DextroseNC193764, 2027, NC195232600 mgNDC 0338-3612-50
Pantoprazole Sodium in 0.9% Sodium Chloride InjectionNC194129, 202880 mgNDC 0338-9648-12
Clindamycin Injection USP in 5% DextroseNC194068, 2027900 mgNDC 43066-995-24

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Manufacturing Deviation recalls

Other recent recalls from Baxter Healthcare Corporation

All recalls from Baxter Healthcare Corporation

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-30 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification